These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25303993)

  • 1. Modifications to toxic CUG RNAs induce structural stability, rescue mis-splicing in a myotonic dystrophy cell model and reduce toxicity in a myotonic dystrophy zebrafish model.
    deLorimier E; Coonrod LA; Copperman J; Taber A; Reister EE; Sharma K; Todd PK; Guenza MG; Berglund JA
    Nucleic Acids Res; 2014 Nov; 42(20):12768-78. PubMed ID: 25303993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.
    Wong CH; Nguyen L; Peh J; Luu LM; Sanchez JS; Richardson SL; Tuccinardi T; Tsoi H; Chan WY; Chan HY; Baranger AM; Hergenrother PJ; Zimmerman SC
    J Am Chem Soc; 2014 Apr; 136(17):6355-61. PubMed ID: 24702247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1.
    Pettersson OJ; Aagaard L; Andrejeva D; Thomsen R; Jensen TG; Damgaard CK
    Nucleic Acids Res; 2014 Jun; 42(11):7186-200. PubMed ID: 24792155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
    Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
    Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats.
    Laurent FX; Sureau A; Klein AF; Trouslard F; Gasnier E; Furling D; Marie J
    Nucleic Acids Res; 2012 Apr; 40(7):3159-71. PubMed ID: 22156369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
    Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
    PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1.
    Wojciechowska M; Taylor K; Sobczak K; Napierala M; Krzyzosiak WJ
    RNA Biol; 2014; 11(6):742-54. PubMed ID: 24824895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.
    Sobczak K; Wheeler TM; Wang W; Thornton CA
    Mol Ther; 2013 Feb; 21(2):380-7. PubMed ID: 23183533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain.
    Wang PY; Kuo TY; Wang LH; Liang WH; Wang GS
    Acta Neuropathol Commun; 2023 Mar; 11(1):44. PubMed ID: 36922901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dimeric Form of 1,3-Diaminoisoquinoline Derivative Rescued the Mis-splicing of Atp2a1 and Clcn1 Genes in Myotonic Dystrophy Type 1 Mouse Model.
    Matsumoto J; Nakamori M; Okamoto T; Murata A; Dohno C; Nakatani K
    Chemistry; 2020 Nov; 26(63):14305-14309. PubMed ID: 32449537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models.
    García-López A; Llamusí B; Orzáez M; Pérez-Payá E; Artero RD
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11866-71. PubMed ID: 21730182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1.
    Todd PK; Ackall FY; Hur J; Sharma K; Paulson HL; Dowling JJ
    Dis Model Mech; 2014 Jan; 7(1):143-55. PubMed ID: 24092878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a
    Chakraborty M; Sellier C; Ney M; Pascal V; Charlet-Berguerand N; Artero R; Llamusi B
    Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29592894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudouridine Modification Inhibits Muscleblind-like 1 (MBNL1) Binding to CCUG Repeats and Minimally Structured RNA through Reduced RNA Flexibility.
    deLorimier E; Hinman MN; Copperman J; Datta K; Guenza M; Berglund JA
    J Biol Chem; 2017 Mar; 292(10):4350-4357. PubMed ID: 28130447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.
    Herrendorff R; Faleschini MT; Stiefvater A; Erne B; Wiktorowicz T; Kern F; Hamburger M; Potterat O; Kinter J; Sinnreich M
    J Biol Chem; 2016 Aug; 291(33):17165-77. PubMed ID: 27298317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.